C. Lindemalm

1.1k total citations
39 papers, 838 citations indexed

About

C. Lindemalm is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, C. Lindemalm has authored 39 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 14 papers in Pathology and Forensic Medicine and 12 papers in Genetics. Recurrent topics in C. Lindemalm's work include Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). C. Lindemalm is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). C. Lindemalm collaborates with scholars based in Sweden, United States and Denmark. C. Lindemalm's co-authors include Håkan Mellstedt, Peter Strang, Magnus Björkholm, Leif Bergkvist, Peter Biberfeld, Mats Lekander, G. Holm, B. Johansson, Birger Christensson and Giuseppe Masucci and has published in prestigious journals such as British Journal of Cancer, International Journal of Cancer and Journal of Psychosomatic Research.

In The Last Decade

C. Lindemalm

39 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Lindemalm Sweden 17 428 260 176 147 142 39 838
TA Lister United Kingdom 19 405 0.9× 189 0.7× 532 3.0× 116 0.8× 71 0.5× 32 1.0k
E. S. Henderson United States 17 304 0.7× 176 0.7× 193 1.1× 352 2.4× 45 0.3× 33 909
Clare J. Twist United States 14 270 0.6× 148 0.6× 100 0.6× 278 1.9× 61 0.4× 43 1.2k
R Powles United Kingdom 19 258 0.6× 228 0.9× 54 0.3× 645 4.4× 47 0.3× 52 1.1k
C. C. Zielinski Austria 16 264 0.6× 204 0.8× 79 0.4× 39 0.3× 60 0.4× 45 927
Elisabetta Todisco Italy 19 487 1.1× 257 1.0× 289 1.6× 410 2.8× 25 0.2× 56 1.1k
David Andorsky United States 15 555 1.3× 264 1.0× 397 2.3× 97 0.7× 34 0.2× 71 1.2k
Paul Greaves United Kingdom 10 384 0.9× 311 1.2× 309 1.8× 56 0.4× 31 0.2× 24 731
Taner Babacan Türkiye 15 409 1.0× 65 0.3× 142 0.8× 70 0.5× 59 0.4× 52 788
JP Marie France 14 736 1.7× 103 0.4× 102 0.6× 436 3.0× 43 0.3× 26 1.4k

Countries citing papers authored by C. Lindemalm

Since Specialization
Citations

This map shows the geographic impact of C. Lindemalm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Lindemalm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Lindemalm more than expected).

Fields of papers citing papers by C. Lindemalm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Lindemalm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Lindemalm. The network helps show where C. Lindemalm may publish in the future.

Co-authorship network of co-authors of C. Lindemalm

This figure shows the co-authorship network connecting the top 25 collaborators of C. Lindemalm. A scholar is included among the top collaborators of C. Lindemalm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Lindemalm. C. Lindemalm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rosenblad, Andreas, et al.. (2012). Long-term follow-up of a randomized study of support group intervention in women with primary breast cancer. Journal of Psychosomatic Research. 74(4). 346–353. 31 indexed citations
2.
Lindemalm, C., et al.. (2012). A randomized controlled trial of a support group intervention on the quality of life and fatigue in women after primary treatment for early breast cancer. Supportive Care in Cancer. 20(12). 3325–3334. 31 indexed citations
3.
Lindemalm, C., et al.. (2011). A randomised controlled trial of support group intervention after breast cancer treatment: Results on anxiety and depression. Acta Oncologica. 51(2). 198–207. 34 indexed citations
4.
Mozaffari, Fariba, C. Lindemalm, Aniruddha Choudhury, et al.. (2008). Systemic immune effects of adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide and/or radiotherapy in breast cancer: a longitudinal study. Cancer Immunology Immunotherapy. 58(1). 111–120. 26 indexed citations
5.
Mozaffari, Fariba, C. Lindemalm, A Choudhury, et al.. (2007). NK-cell and T-cell functions in patients with breast cancer: effects of surgery and adjuvant chemo- and radiotherapy. British Journal of Cancer. 97(1). 105–111. 65 indexed citations
6.
Lindemalm, C., Peter Strang, & Mats Lekander. (2005). Support group for cancer patients. Does it improve their physical and psychological wellbeing? A pilot study. Supportive Care in Cancer. 13(8). 652–657. 35 indexed citations
7.
Wersäll, Jan, Giuseppe Masucci, Peter Ragnhammar, et al.. (1993). Low dose cyclophosphamide, alpha-interferon and continuous infusions of interleukin-2 in advanced renal cell carcinoma. Medical Oncology and Tumor Pharmacotherapy. 10(3). 103–111. 12 indexed citations
8.
Merk, K., Bo Johansson, Eva Kimby, et al.. (1991). Mitoxantrone, etoposide, cytarabine and prednisone as salvage therapy for refractory non‐Hodgkin lymphoma (NHL) and alternated with CHOP in previously untreated patients with NHL. European Journal Of Haematology. 46(1). 33–37. 8 indexed citations
9.
Mellstedt, Hákan, Peter Ragnhammar, Giuseppe Masucci, et al.. (1991). Therapy of Colorectal Carcinoma with Monoclonal Antibodies (MAb17-1A) Alone and in Combination with Granulocyte Monocyte-Colony Stimulating Factor (GM-CSF). Acta Oncologica. 30(8). 923–931. 15 indexed citations
10.
Enblad, Gunilla, Bengt Glimelius, Hans Hagberg, & C. Lindemalm. (1990). Methyl-Gag, Ifosfamide, Methotrexate and Etoposide (Mime) as Salvage Therapy for Hodgkin's Disease and Non-Hodgkin's Lymphoma. Acta Oncologica. 29(3). 297–301. 15 indexed citations
11.
Mellstedt, Håkan, Giuseppe Masucci, C. Lindemalm, et al.. (1989). Monoclonal antibodies (MAb 17-1A) for the treatment of patients with metastatic colorectal carcinomas.. PubMed. 549. 63–70. 6 indexed citations
12.
Christensson, Birger, C. Lindemalm, B. Johansson, et al.. (1989). Flow cytometric DNA analysis: A prognostic tool in non-hodgkin's lymphoma. Leukemia Research. 13(4). 307–314. 32 indexed citations
13.
14.
Kimby, Eva, Håkan Mellstedt, Bo Nilsson, et al.. (1988). Blood lymphocyte characteristics as predictors of prognosis in chronic lymphocytic leukemia of B‐cell type. Hematological Oncology. 6(1). 47–55. 9 indexed citations
15.
Lindemalm, C., Birger Christensson, Gunnel Biberfeld, et al.. (1988). Prognostic significance of immunoglobulin isotype expression in B-cell non-Hodgkin’s lymphoma. Medical Oncology and Tumor Pharmacotherapy. 5(4). 243–248. 3 indexed citations
16.
Robert, KH, Gösta Gahrton, H Mellstedt, et al.. (1988). Therapeutic effects of low‐dose cytosine arabinoside, alpha‐interferon, 1α‐hydroxyvitamin D3 and retinoic acid in acute leukemia and myelodysplastic syndromes. European Journal Of Haematology. 40(5). 449–459. 42 indexed citations
17.
Biberfeld, Peter, et al.. (1988). Human herpesvirus-6 (HHV-6, HBLV) in sarcoidosis and lymphoproliferative disorders. Journal of Virological Methods. 21(1-4). 49–59. 69 indexed citations
18.
Lindemalm, C., H Mellstedt, Bo Nilsson, et al.. (1987). Blood clonal B cell excess (CBE) at diagnosis in patients with non-Hodgkin lymphoma (NHL). Relation to clinical stage, histopathology and response to treatment. European Journal of Cancer and Clinical Oncology. 23(6). 749–753. 8 indexed citations
19.
Lindemalm, C., Magnus Björkholm, G. Holm, B. Johansson, & Håkan Mellstedt. (1983). Mitogen Induced Blood Lymphocyte DNA Synthesis as a Prognostic Indicator in Patients with Non-Hodgkin's Lymphomas in Clinical Remission. Acta Radiologica Oncology. 22(6). 455–459. 2 indexed citations
20.
Christensson, Birger, C. Lindemalm, Bo Johansson, et al.. (1983). CORRELATION OF IMMUNOPHENOTYPE TO MORPHOLOGY IN UNFAVOURABLE NON‐HODGKIN LYMPHOMA. Acta Pathologica Microbiologica Scandinavica Series A Pathology. 91A(1-6). 425–433. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by TA Lister Breakdown of academic impact, for papers by E. S. Henderson Breakdown of academic impact, for papers by Clare J. Twist Breakdown of academic impact, for papers by R Powles Breakdown of academic impact, for papers by C. C. Zielinski Breakdown of academic impact, for papers by Elisabetta Todisco Breakdown of academic impact, for papers by David Andorsky Breakdown of academic impact, for papers by Paul Greaves Breakdown of academic impact, for papers by Taner Babacan Breakdown of academic impact, for papers by JP Marie
Rankless by CCL
2026